Preparing for the unpredictable: The continuing need for pandemic influenza preparedness

Vaccine

Volumn 34, Issue 45, 2016, Pages 5391-5392

  Gellin, Bruce G ^a   Qadri, Firdausi ^b  

^a U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^b INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

EDITORIAL; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; INFLUENZA VACCINATION; INFLUENZA VIRUS; PANDEMIC INFLUENZA; PRIORITY JOURNAL; PUBLIC HEALTH; VACCINE PRODUCTION; WORLD HEALTH ORGANIZATION; DISASTER PLANNING; INFLUENZA; ORGANIZATION AND MANAGEMENT; PANDEMIC; SUPPLY AND DISTRIBUTION;

DISASTER PLANNING; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; PANDEMICS;

EID: 84992671843     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.09.023     Document Type: Editorial

References (18)

1. [1] Fan VY, Jamison DT, Summers LH. The inclusive cost of pandemic influenza risk (working paper 22137). Cambridge, MA: National Bureau of Economic Research; 2016. < http://www.nber.org/papers/w22137>.
2. [2] An R&D blueprint for action to prevent epidemics. Accelerating R&D and saving lives. Geneva: World Health Organization. < http://www.who.int/csr/research-and-development/r_d_blueprint_brochure2015.pdf?ua=1>.
3. [3] Giersing, B.K., Modjarradb, K., Kaslow, D.C., Moorthya, V.S., Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7–9 September 2015. Vaccine 34 (2016), 2865–2869.
4. [4] Antibiotic resistance threats in the United States, 2013. Atlanta, GA: Centers for Disease Control and Prevention; 2013. < http://www.cdc.gov/drugresistance/threat-report-2013/index.html>.
5. [5] US Federal Select Agents and Toxins List. < http://www.selectagents.gov/SelectAgentsandToxinsList.html>.
6. [6] The Coalition for Epidemic Preparedness Innovations (CEPI). < http://cepi.net/>.
7. [7] Plotkin, S.A., Mahmoud, A.A.F., Farrar, J., Establishing a global vaccine-development fund (perspective). N Engl J Med 373 (2015), 297–300.
8. [8] Osterholm MT, Kelley N, Manske JM, Ballering KS, Leighton TR, Moore KA. The compelling need for game-changing influenza vaccines. Minnesota: Center for Infectious Disease Research and Policy. < http://www.cidrap.umn.edu/compelling-need-game-changing-influenza-vaccines>.
9. [9] Krammer, F., Palese, P., Advances in the development of influenza virus vaccines. Nat Rev Drug Discovery 14 (2015), 167–182.
10. [10] Nabel, G.J., Fauci, A.S., Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine (commentary). Nat Med 16 (2010), 1389–1391.
11. [11] Global Vaccine Action Plan 2011–2020. Geneva: World Health Organization. < http://www.who.int/immunization/global_vaccine_action_plan/GVAP_doc_2011_2020/en/>.
12. [12] Eskola, J., Duclos, P., Schuster, M., MacDonald, N.E., SAGE Working Group on Vaccine Hesitancy. How to deal with vaccine hesitancy?. Vaccine 33:34 (2015), 4215–4217.
13. [13] Global Action Plan for Influenza Vaccines. Geneva: World Health Organization. < http://www.who.int/influenza_vaccines_plan/objectives/en/>.
14. [14] Pandemic Influenza Preparedness (PIP) Framework. Geneva: World Health Organization. < http://www.who.int/influenza/pip/en/; http://www.who.int/influenza/pip/2016-review/en/>.
15. [15] http://www.who.int/mediacentre/news/releases/2016/wha69-25-may-2016/en/.
16. [16] WHO Global Influenza Surveillance and Response System (GISR). Melbourne: Peter Doherty Institute for Infection and Immunity. < http://www.influenzacentre.org/centre_GISRS.htm>.
17. [17] Global Action Plan for Influenza Vaccines. Global progress report, January 2006–September 2013. Geneva: World Health Organization. < http://apps.who.int/iris/bitstream/10665/112307/1/9789241507011_eng.pdf?ua=1>.
18. [18] Silva, M.L., Perrier, L., Cohen, J.M., Paget, W.J., Mosnier, A., Späth, H.M., A literature review to identify factors that determine policies for influenza vaccination. Health Policy 119 (2015), 697–708.